132 related articles for article (PubMed ID: 9049842)
21. Meta-iodobenzylguanidine uptake in platelets, megakaryoblastic leukaemia cell lines MKPL-1 and CHRF-28-11 and erythroleukaemic cell line HEL.
Tytgat GA; Voûte PA; Takeuchi S; Miyoshi I; Rutgers M
Eur J Cancer; 1995; 31A(4):603-6. PubMed ID: 7576978
[TBL] [Abstract][Full Text] [Related]
22. Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma.
Mairs RJ; Russell J; Cunningham S; O'Donoghue JA; Gaze MN; Owens J; Vaidyanathan G; Zalutsky MR
Eur J Cancer; 1995; 31A(4):576-81. PubMed ID: 7576972
[TBL] [Abstract][Full Text] [Related]
23. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
Babich JW; Graham WA; Fischman AJ
Br J Cancer; 1996 Sep; 74(6):917-24. PubMed ID: 8826858
[TBL] [Abstract][Full Text] [Related]
25. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
26. Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux.
Servidei T; Iavarone A; Lasorella A; Mastrangelo S; Riccardi R
Eur J Cancer; 1995; 31A(4):591-5. PubMed ID: 7576975
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
Bruchelt G; Girgert R; Buck J; Wolburg H; Niethammer D; Treuner J
Cancer Res; 1988 Jun; 48(11):2993-7. PubMed ID: 3365688
[TBL] [Abstract][Full Text] [Related]
28. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
Buck J; Bruchelt G; Girgert R; Treuner J; Niethammer D
Cancer Res; 1985 Dec; 45(12 Pt 1):6366-70. PubMed ID: 3864530
[TBL] [Abstract][Full Text] [Related]
29. The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro.
Armour A; Cunningham SH; Gaze MN; Wheldon TE; Mairs RJ
Br J Cancer; 1997; 75(4):470-6. PubMed ID: 9052395
[TBL] [Abstract][Full Text] [Related]
30. Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction.
Mairs RJ; Livingstone A; Gaze MN; Wheldon TE; Barrett A
Br J Cancer; 1994 Jul; 70(1):97-101. PubMed ID: 7517173
[TBL] [Abstract][Full Text] [Related]
31. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
Clerc J; Halpern S; Fourré C; Omri F; Briançon C; Jeusset J; Fragu P
J Nucl Med; 1993 Sep; 34(9):1565-70. PubMed ID: 8355077
[TBL] [Abstract][Full Text] [Related]
32. A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
Rutgers M; Gubbels AA; Hoefnagel CA; Voûte PA; Smets LA
Prog Clin Biol Res; 1991; 366():471-8. PubMed ID: 2068162
[No Abstract] [Full Text] [Related]
33. Uptake and washout of I-123-MIBG in neuronal and non-neuronal sites in rat hearts: relationship to renal clearance.
Arbab AS; Koizumi K; Araki T
Ann Nucl Med; 1996 May; 10(2):211-7. PubMed ID: 8800450
[TBL] [Abstract][Full Text] [Related]
34. The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.
Mairs RJ; Gaze MN; Barrett A
Br J Cancer; 1991 Aug; 64(2):293-5. PubMed ID: 1892758
[No Abstract] [Full Text] [Related]
35. Comparison of MIBG and monoamines uptake mechanisms: pharmacological animal and blood platelets studies.
Guilloteau D; Chalon S; Baulieu JL; Huguet F; Desplanches G; Chambon C; Vilar MP; Pourcelot L; Besnard JC
Eur J Nucl Med; 1988; 14(7-8):341-4. PubMed ID: 3141186
[TBL] [Abstract][Full Text] [Related]
36. A human neuroblastoma xenograft model for 125-I-metaiodobenzylguanidine biodistribution studies.
Lavitrano M; Servidei T; Mastrangelo S; Tornesello A; Fioretti D; Di Stefano C; Riccardi A; Franceschini R; Riccardi R
J Neurooncol; 1997 Jan; 31(1-2):159-64. PubMed ID: 9049844
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
[No Abstract] [Full Text] [Related]
38. Radiolabeled meta-iodobenzylguanidine and the adrenergic neurons of salivary glands.
Sisson JC; Wieland DM; Jaques S; Sherman P; Fisher S; Mallette S; Meyers L; Mangner TJ
Am J Physiol Imaging; 1987; 2(1):1-9. PubMed ID: 3451762
[TBL] [Abstract][Full Text] [Related]
39. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
Vaidyanathan G; Welsh PC; Vitorello KC; Snyder S; Friedman HS; Zalutsky MR
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1362-70. PubMed ID: 15205923
[TBL] [Abstract][Full Text] [Related]
40. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.
Lode HN; Bruchelt G; Seitz G; Gebhardt S; Gekeler V; Niethammer D; Beck J
Eur J Cancer; 1995; 31A(4):586-90. PubMed ID: 7576974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
